| PTRMX | TEAFX | PTRMX / TEAFX | |
| Total Expense Ratio | 0.74 | 0.38 | 195% |
| Annual Report Gross Expense Ratio | 0.74 | 0.38 | 195% |
| Fund Existence | 13 years | 17 years | - |
| Gain YTD | 3.539 | 0.807 | 438% |
| Front Load | 2% | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 671M | 23.9B | 3% |
| Annual Yield % from dividends | 3.50 | 3.19 | 109% |
| Returns for 1 year | 3.09 | 0.33 | 945% |
| Returns for 3 years | 14.37 | 5.10 | 282% |
| Returns for 5 years | 0.80 | -6.95 | -12% |
| Returns for 10 years | 21.23 | -0.64 | -3,302% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ROBN | 66.66 | 4.21 | +6.74% |
| T-Rex 2X Long HOOD Daily Target ETF | |||
| IHE | 82.09 | 0.23 | +0.28% |
| iShares US Pharmaceuticals ETF | |||
| IMAR | 29.06 | N/A | N/A |
| Innovator Intl Dev Pwr Bffr ETF - Mar | |||
| MBSF | 25.55 | -0.05 | -0.18% |
| Regan Floating Rate MBS ETF | |||
| IWS | 135.53 | -0.42 | -0.31% |
| iShares Russell Mid-Cap Value ETF | |||